Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The Department of Oncology is pleased to announce that Professor Amato J Giaccia has been appointed as the new Director of the MRC Oxford Institute for Radiation Oncology (OIRO).

Professor Amato Giaccia

Professor Giaccia joins the Department after many successful years as Director of the Division of Radiation & Cancer Biology at the University of Stanford, California.  He is internationally recognised for his contribution to understanding the role of tumour microenvironment, hypoxia, and HIF-1-mediated pathways in cancer.  He has more than 20 years of experience in his field of research with over 200 publications in addition to serving on a number of committees and editorial boards.

His international standing, plus his wealth of experience in the field of radiation oncology will ensure the continued success of OIRO and its close working relationships with cancer collaborators and major funding bodies.  Professor Gavin Screaton, Head of the Medical Sciences Division, commented: ‘Amato is a fantastic catch for the Oxford oncology community and we are delighted he has chosen to join us from Stanford. He has already made his presence felt having hit the ground running and we look forward to him taking the Institute to the next level’.

Professor Mark Middleton, Head of the Department of Oncology, said:   ‘The Department of Oncology is excited that Professor Giaccia has agreed to join us at such a momentous time to help us secure the future of OIRO and the contribution it makes to the world of radiation oncology’.

Dr Mariana Delfino-Machin, MRC Programme Manager for Cancer, said: ‘OIRO is the MRC’s major strategic investment in radiation oncology research and the appointment of Professor Giaccia provides a platform for OIRO to build upon its significant discoveries in the field.  Professor Giaccia is an excellent addition to the UK’s radiation oncology community’.

Similar stories

OUH agrees long COVID research collaboration with Polarean

The collaboration will look at understanding the long-term effects of COVID-19 through cutting-edge MRI analysis.

Lung abnormalities found in long COVID patients with breathlessness

Researchers have identified abnormalities in the lungs of long COVID patients who are experiencing breathlessness that cannot be detected with routine tests.

New blood-based test is the first ever to simultaneously identify if a patient has cancer and if it has spread

A publication by University of Oxford researchers describes a new minimally invasive and inexpensive blood test that can identify cancer in patients with non-specific symptoms. The early success of this technology makes it the first blood-based test that not only detects cancer in this population but can simultaneously identify if a cancer has spread.

Eileen Parkes secures Clinical Research Career Development Fellowship

Eileen is awarded funding for her research into the tumour microenvironment

MP Anneliese Dodds tours Oxford cancer research

Anneliese Dodds, MP for Oxford East & Chair of the Labour Party, visited the University of Oxford to learn more about the impactful work happening across departments in the field of cancer research.